Ambu A/S
Ambu A/S (AMBBY) Stock Competitors & Peer Comparison
See (AMBBY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMBBY | $10.32 | -3.13% | 2.7B | 32.24 | $0.32 | +0.33% |
| SMMNY | $20.44 | -1.97% | 92B | 18.58 | $1.10 | +1.79% |
| SEMHF | $42.06 | -0.86% | 47B | 19.21 | $2.19 | +2.07% |
| RYLPF | $26.46 | +0.01% | 25.2B | 24.50 | $1.08 | +3.61% |
| SNNUF | $16.05 | +0.00% | 13.6B | 22.29 | $0.72 | +3.88% |
| SONVY | $43.15 | -0.53% | 12.9B | 19.53 | $2.21 | +2.49% |
| SONVF | $214.70 | +2.95% | 12.8B | 19.43 | $11.05 | +2.53% |
| CHEOF | $119.01 | +1.88% | 7.8B | 28.96 | $4.11 | +2.47% |
| CHEOY | $58.29 | +2.95% | 7.6B | 31.49 | $1.85 | +2.25% |
| WILLF | $28.30 | +0.00% | 6B | 16.26 | $1.74 | N/A |
Stock Comparison
AMBBY vs SMMNY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, SMMNY has a market cap of 92B. Regarding current trading prices, AMBBY is priced at $10.32, while SMMNY trades at $20.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas SMMNY's P/E ratio is 18.58. In terms of profitability, AMBBY's ROE is +0.09%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, AMBBY is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check SMMNY's competition here
AMBBY vs SEMHF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, SEMHF has a market cap of 47B. Regarding current trading prices, AMBBY is priced at $10.32, while SEMHF trades at $42.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas SEMHF's P/E ratio is 19.21. In terms of profitability, AMBBY's ROE is +0.09%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, AMBBY is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check SEMHF's competition here
AMBBY vs RYLPF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, RYLPF has a market cap of 25.2B. Regarding current trading prices, AMBBY is priced at $10.32, while RYLPF trades at $26.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas RYLPF's P/E ratio is 24.50. In terms of profitability, AMBBY's ROE is +0.09%, compared to RYLPF's ROE of +0.08%. Regarding short-term risk, AMBBY and RYLPF have similar daily volatility (0.00).Check RYLPF's competition here
AMBBY vs SNNUF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, SNNUF has a market cap of 13.6B. Regarding current trading prices, AMBBY is priced at $10.32, while SNNUF trades at $16.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas SNNUF's P/E ratio is 22.29. In terms of profitability, AMBBY's ROE is +0.09%, compared to SNNUF's ROE of +0.12%. Regarding short-term risk, AMBBY and SNNUF have similar daily volatility (0.00).Check SNNUF's competition here
AMBBY vs SONVY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, SONVY has a market cap of 12.9B. Regarding current trading prices, AMBBY is priced at $10.32, while SONVY trades at $43.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas SONVY's P/E ratio is 19.53. In terms of profitability, AMBBY's ROE is +0.09%, compared to SONVY's ROE of +0.20%. Regarding short-term risk, AMBBY is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check SONVY's competition here
AMBBY vs SONVF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, SONVF has a market cap of 12.8B. Regarding current trading prices, AMBBY is priced at $10.32, while SONVF trades at $214.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas SONVF's P/E ratio is 19.43. In terms of profitability, AMBBY's ROE is +0.09%, compared to SONVF's ROE of +0.20%. Regarding short-term risk, AMBBY and SONVF have similar daily volatility (0.00).Check SONVF's competition here
AMBBY vs CHEOF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, CHEOF has a market cap of 7.8B. Regarding current trading prices, AMBBY is priced at $10.32, while CHEOF trades at $119.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas CHEOF's P/E ratio is 28.96. In terms of profitability, AMBBY's ROE is +0.09%, compared to CHEOF's ROE of +0.18%. Regarding short-term risk, AMBBY is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check CHEOF's competition here
AMBBY vs CHEOY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, CHEOY has a market cap of 7.6B. Regarding current trading prices, AMBBY is priced at $10.32, while CHEOY trades at $58.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas CHEOY's P/E ratio is 31.49. In terms of profitability, AMBBY's ROE is +0.09%, compared to CHEOY's ROE of +0.18%. Regarding short-term risk, AMBBY is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check CHEOY's competition here
AMBBY vs WILLF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, WILLF has a market cap of 6B. Regarding current trading prices, AMBBY is priced at $10.32, while WILLF trades at $28.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas WILLF's P/E ratio is 16.26. In terms of profitability, AMBBY's ROE is +0.09%, compared to WILLF's ROE of +0.16%. Regarding short-term risk, AMBBY and WILLF have similar daily volatility (0.00).Check WILLF's competition here
AMBBY vs WILYY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, WILYY has a market cap of 5.9B. Regarding current trading prices, AMBBY is priced at $10.32, while WILYY trades at $13.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas WILYY's P/E ratio is 15.46. In terms of profitability, AMBBY's ROE is +0.09%, compared to WILYY's ROE of +0.16%. Regarding short-term risk, AMBBY and WILYY have similar daily volatility (0.00).Check WILYY's competition here
AMBBY vs GNGBF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, GNGBF has a market cap of 5.9B. Regarding current trading prices, AMBBY is priced at $10.32, while GNGBF trades at $23.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas GNGBF's P/E ratio is 25.25. In terms of profitability, AMBBY's ROE is +0.09%, compared to GNGBF's ROE of +0.08%. Regarding short-term risk, AMBBY and GNGBF have similar daily volatility (0.00).Check GNGBF's competition here
AMBBY vs GNGBY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, GNGBY has a market cap of 5.3B. Regarding current trading prices, AMBBY is priced at $10.32, while GNGBY trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas GNGBY's P/E ratio is 21.74. In terms of profitability, AMBBY's ROE is +0.09%, compared to GNGBY's ROE of +0.08%. Regarding short-term risk, AMBBY is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check GNGBY's competition here
AMBBY vs AMBFF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, AMBFF has a market cap of 3.7B. Regarding current trading prices, AMBBY is priced at $10.32, while AMBFF trades at $13.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas AMBFF's P/E ratio is 42.66. In terms of profitability, AMBBY's ROE is +0.09%, compared to AMBFF's ROE of +0.09%. Regarding short-term risk, AMBBY and AMBFF have similar daily volatility (0.00).Check AMBFF's competition here
AMBBY vs NHNKY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, NHNKY has a market cap of 2.9B. Regarding current trading prices, AMBBY is priced at $10.32, while NHNKY trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas NHNKY's P/E ratio is 13.04. In terms of profitability, AMBBY's ROE is +0.09%, compared to NHNKY's ROE of +0.07%. Regarding short-term risk, AMBBY is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check NHNKY's competition here
AMBBY vs MCRPF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, MCRPF has a market cap of 2.9B. Regarding current trading prices, AMBBY is priced at $10.32, while MCRPF trades at $1.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas MCRPF's P/E ratio is -17.44. In terms of profitability, AMBBY's ROE is +0.09%, compared to MCRPF's ROE of -0.27%. Regarding short-term risk, AMBBY and MCRPF have similar daily volatility (0.00).Check MCRPF's competition here
AMBBY vs NHNKF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, NHNKF has a market cap of 2.4B. Regarding current trading prices, AMBBY is priced at $10.32, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, AMBBY's ROE is +0.09%, compared to NHNKF's ROE of +0.07%. Regarding short-term risk, AMBBY and NHNKF have similar daily volatility (0.00).Check NHNKF's competition here
AMBBY vs GNNDY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, GNNDY has a market cap of 2.1B. Regarding current trading prices, AMBBY is priced at $10.32, while GNNDY trades at $43.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas GNNDY's P/E ratio is 20.83. In terms of profitability, AMBBY's ROE is +0.09%, compared to GNNDY's ROE of +0.06%. Regarding short-term risk, AMBBY is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check GNNDY's competition here
AMBBY vs DRWKF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, DRWKF has a market cap of 2.1B. Regarding current trading prices, AMBBY is priced at $10.32, while DRWKF trades at $109.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas DRWKF's P/E ratio is 12.70. In terms of profitability, AMBBY's ROE is +0.09%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, AMBBY and DRWKF have similar daily volatility (0.00).Check DRWKF's competition here
AMBBY vs GGNDF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, GGNDF has a market cap of 2B. Regarding current trading prices, AMBBY is priced at $10.32, while GGNDF trades at $13.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas GGNDF's P/E ratio is 19.64. In terms of profitability, AMBBY's ROE is +0.09%, compared to GGNDF's ROE of +0.06%. Regarding short-term risk, AMBBY and GGNDF have similar daily volatility (0.00).Check GGNDF's competition here
AMBBY vs FDMDF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, FDMDF has a market cap of 1.8B. Regarding current trading prices, AMBBY is priced at $10.32, while FDMDF trades at $3.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas FDMDF's P/E ratio is -11.29. In terms of profitability, AMBBY's ROE is +0.09%, compared to FDMDF's ROE of -9.21%. Regarding short-term risk, AMBBY and FDMDF have similar daily volatility (0.00).Check FDMDF's competition here
AMBBY vs OSSFF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, AMBBY is priced at $10.32, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas OSSFF's P/E ratio is 20.75. In terms of profitability, AMBBY's ROE is +0.09%, compared to OSSFF's ROE of +0.10%. Regarding short-term risk, AMBBY and OSSFF have similar daily volatility (0.00).Check OSSFF's competition here
AMBBY vs DWRKF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, AMBBY is priced at $10.32, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, AMBBY's ROE is +0.09%, compared to DWRKF's ROE of N/A. Regarding short-term risk, AMBBY and DWRKF have similar daily volatility (0.00).Check DWRKF's competition here
AMBBY vs STSEY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, STSEY has a market cap of 1.7B. Regarding current trading prices, AMBBY is priced at $10.32, while STSEY trades at $5.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas STSEY's P/E ratio is 19.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to STSEY's ROE of +0.07%. Regarding short-term risk, AMBBY and STSEY have similar daily volatility (0.00).Check STSEY's competition here
AMBBY vs MEDGF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, AMBBY is priced at $10.32, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, AMBBY's ROE is +0.09%, compared to MEDGF's ROE of +0.22%. Regarding short-term risk, AMBBY and MEDGF have similar daily volatility (0.00).Check MEDGF's competition here
AMBBY vs OSSUY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, OSSUY has a market cap of 1.6B. Regarding current trading prices, AMBBY is priced at $10.32, while OSSUY trades at $3.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas OSSUY's P/E ratio is 19.08. In terms of profitability, AMBBY's ROE is +0.09%, compared to OSSUY's ROE of +0.10%. Regarding short-term risk, AMBBY and OSSUY have similar daily volatility (0.00).Check OSSUY's competition here
AMBBY vs VTRLY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, VTRLY has a market cap of 1.5B. Regarding current trading prices, AMBBY is priced at $10.32, while VTRLY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas VTRLY's P/E ratio is -2.77. In terms of profitability, AMBBY's ROE is +0.09%, compared to VTRLY's ROE of -0.42%. Regarding short-term risk, AMBBY and VTRLY have similar daily volatility (0.00).Check VTRLY's competition here
AMBBY vs DGWPF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, DGWPF has a market cap of 1.5B. Regarding current trading prices, AMBBY is priced at $10.32, while DGWPF trades at $76.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas DGWPF's P/E ratio is 8.89. In terms of profitability, AMBBY's ROE is +0.09%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, AMBBY and DGWPF have similar daily volatility (0.00).Check DGWPF's competition here
AMBBY vs MDRSF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, MDRSF has a market cap of 1.4B. Regarding current trading prices, AMBBY is priced at $10.32, while MDRSF trades at $115.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas MDRSF's P/E ratio is 135.29. In terms of profitability, AMBBY's ROE is +0.09%, compared to MDRSF's ROE of +0.03%. Regarding short-term risk, AMBBY and MDRSF have similar daily volatility (0.00).Check MDRSF's competition here
AMBBY vs ELEAF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, ELEAF has a market cap of 1.3B. Regarding current trading prices, AMBBY is priced at $10.32, while ELEAF trades at $16.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas ELEAF's P/E ratio is 23.06. In terms of profitability, AMBBY's ROE is +0.09%, compared to ELEAF's ROE of +0.16%. Regarding short-term risk, AMBBY and ELEAF have similar daily volatility (0.00).Check ELEAF's competition here
AMBBY vs LFTSF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, AMBBY is priced at $10.32, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, AMBBY's ROE is +0.09%, compared to LFTSF's ROE of +0.02%. Regarding short-term risk, AMBBY and LFTSF have similar daily volatility (0.00).Check LFTSF's competition here
AMBBY vs XVIPF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, XVIPF has a market cap of 603.2M. Regarding current trading prices, AMBBY is priced at $10.32, while XVIPF trades at $19.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas XVIPF's P/E ratio is 212.78. In terms of profitability, AMBBY's ROE is +0.09%, compared to XVIPF's ROE of +0.01%. Regarding short-term risk, AMBBY and XVIPF have similar daily volatility (0.00).Check XVIPF's competition here
AMBBY vs AVMR Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, AMBBY is priced at $10.32, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas AVMR's P/E ratio is -18.34. In terms of profitability, AMBBY's ROE is +0.09%, compared to AVMR's ROE of -0.30%. Regarding short-term risk, AMBBY and AVMR have similar daily volatility (0.00).Check AVMR's competition here
AMBBY vs DMTRF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, DMTRF has a market cap of 476M. Regarding current trading prices, AMBBY is priced at $10.32, while DMTRF trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas DMTRF's P/E ratio is -198.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to DMTRF's ROE of +0.36%. Regarding short-term risk, AMBBY and DMTRF have similar daily volatility (0.00).Check DMTRF's competition here
AMBBY vs BRSYF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, BRSYF has a market cap of 475.2M. Regarding current trading prices, AMBBY is priced at $10.32, while BRSYF trades at $11.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas BRSYF's P/E ratio is 74.19. In terms of profitability, AMBBY's ROE is +0.09%, compared to BRSYF's ROE of +0.12%. Regarding short-term risk, AMBBY and BRSYF have similar daily volatility (0.00).Check BRSYF's competition here
AMBBY vs IOBCF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, IOBCF has a market cap of 439.6M. Regarding current trading prices, AMBBY is priced at $10.32, while IOBCF trades at $15.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas IOBCF's P/E ratio is 22.39. In terms of profitability, AMBBY's ROE is +0.09%, compared to IOBCF's ROE of +0.15%. Regarding short-term risk, AMBBY and IOBCF have similar daily volatility (0.00).Check IOBCF's competition here
AMBBY vs CALZF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, CALZF has a market cap of 414.5M. Regarding current trading prices, AMBBY is priced at $10.32, while CALZF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas CALZF's P/E ratio is 60.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to CALZF's ROE of +0.12%. Regarding short-term risk, AMBBY and CALZF have similar daily volatility (0.00).Check CALZF's competition here
AMBBY vs CLVSF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, CLVSF has a market cap of 384.8M. Regarding current trading prices, AMBBY is priced at $10.32, while CLVSF trades at $16.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas CLVSF's P/E ratio is 23.38. In terms of profitability, AMBBY's ROE is +0.09%, compared to CLVSF's ROE of +0.18%. Regarding short-term risk, AMBBY and CLVSF have similar daily volatility (0.00).Check CLVSF's competition here
AMBBY vs CSSPF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, CSSPF has a market cap of 384.5M. Regarding current trading prices, AMBBY is priced at $10.32, while CSSPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas CSSPF's P/E ratio is 92.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to CSSPF's ROE of +0.10%. Regarding short-term risk, AMBBY and CSSPF have similar daily volatility (0.00).Check CSSPF's competition here
AMBBY vs HYBT Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, AMBBY is priced at $10.32, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas HYBT's P/E ratio is N/A. In terms of profitability, AMBBY's ROE is +0.09%, compared to HYBT's ROE of +0.02%. Regarding short-term risk, AMBBY and HYBT have similar daily volatility (0.00).Check HYBT's competition here
AMBBY vs CYBQY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, CYBQY has a market cap of 338.8M. Regarding current trading prices, AMBBY is priced at $10.32, while CYBQY trades at $1.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas CYBQY's P/E ratio is -190.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to CYBQY's ROE of -0.00%. Regarding short-term risk, AMBBY and CYBQY have similar daily volatility (0.00).Check CYBQY's competition here
AMBBY vs HTLZF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, AMBBY is priced at $10.32, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, AMBBY's ROE is +0.09%, compared to HTLZF's ROE of -0.01%. Regarding short-term risk, AMBBY and HTLZF have similar daily volatility (0.00).Check HTLZF's competition here
AMBBY vs CYBQF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, CYBQF has a market cap of 229.5M. Regarding current trading prices, AMBBY is priced at $10.32, while CYBQF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas CYBQF's P/E ratio is -172.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to CYBQF's ROE of -0.00%. Regarding short-term risk, AMBBY and CYBQF have similar daily volatility (0.00).Check CYBQF's competition here
AMBBY vs IMPZY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, IMPZY has a market cap of 200.8M. Regarding current trading prices, AMBBY is priced at $10.32, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, AMBBY's ROE is +0.09%, compared to IMPZY's ROE of +13.22%. Regarding short-term risk, AMBBY and IMPZY have similar daily volatility (0.00).Check IMPZY's competition here
AMBBY vs VMTHF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, VMTHF has a market cap of 184.7M. Regarding current trading prices, AMBBY is priced at $10.32, while VMTHF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas VMTHF's P/E ratio is -2.01. In terms of profitability, AMBBY's ROE is +0.09%, compared to VMTHF's ROE of -0.30%. Regarding short-term risk, AMBBY and VMTHF have similar daily volatility (0.00).Check VMTHF's competition here
AMBBY vs DTXMF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, AMBBY is priced at $10.32, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, AMBBY's ROE is +0.09%, compared to DTXMF's ROE of -0.74%. Regarding short-term risk, AMBBY and DTXMF have similar daily volatility (0.00).Check DTXMF's competition here
AMBBY vs PXMBF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, PXMBF has a market cap of 149.9M. Regarding current trading prices, AMBBY is priced at $10.32, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, AMBBY's ROE is +0.09%, compared to PXMBF's ROE of -0.04%. Regarding short-term risk, AMBBY and PXMBF have similar daily volatility (0.00).Check PXMBF's competition here
AMBBY vs EKDHF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, EKDHF has a market cap of 146.7M. Regarding current trading prices, AMBBY is priced at $10.32, while EKDHF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas EKDHF's P/E ratio is 33.98. In terms of profitability, AMBBY's ROE is +0.09%, compared to EKDHF's ROE of +0.03%. Regarding short-term risk, AMBBY and EKDHF have similar daily volatility (0.00).Check EKDHF's competition here
AMBBY vs CLLKF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, CLLKF has a market cap of 140.2M. Regarding current trading prices, AMBBY is priced at $10.32, while CLLKF trades at $2.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas CLLKF's P/E ratio is -0.85. In terms of profitability, AMBBY's ROE is +0.09%, compared to CLLKF's ROE of -0.50%. Regarding short-term risk, AMBBY and CLLKF have similar daily volatility (0.00).Check CLLKF's competition here
AMBBY vs EAPIF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, EAPIF has a market cap of 120.9M. Regarding current trading prices, AMBBY is priced at $10.32, while EAPIF trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas EAPIF's P/E ratio is -0.84. In terms of profitability, AMBBY's ROE is +0.09%, compared to EAPIF's ROE of -0.24%. Regarding short-term risk, AMBBY and EAPIF have similar daily volatility (0.00).Check EAPIF's competition here
AMBBY vs AMEUF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, AMBBY is priced at $10.32, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, AMBBY's ROE is +0.09%, compared to AMEUF's ROE of -1.90%. Regarding short-term risk, AMBBY is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check AMEUF's competition here
AMBBY vs SOMNF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, SOMNF has a market cap of 111.7M. Regarding current trading prices, AMBBY is priced at $10.32, while SOMNF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas SOMNF's P/E ratio is -51.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to SOMNF's ROE of -0.05%. Regarding short-term risk, AMBBY and SOMNF have similar daily volatility (0.00).Check SOMNF's competition here
AMBBY vs BCCOY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, BCCOY has a market cap of 103.6M. Regarding current trading prices, AMBBY is priced at $10.32, while BCCOY trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas BCCOY's P/E ratio is -0.62. In terms of profitability, AMBBY's ROE is +0.09%, compared to BCCOY's ROE of -0.50%. Regarding short-term risk, AMBBY and BCCOY have similar daily volatility (0.00).Check BCCOY's competition here
AMBBY vs AVHHL Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, AVHHL has a market cap of 99.4M. Regarding current trading prices, AMBBY is priced at $10.32, while AVHHL trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas AVHHL's P/E ratio is -2.22. In terms of profitability, AMBBY's ROE is +0.09%, compared to AVHHL's ROE of +4.77%. Regarding short-term risk, AMBBY and AVHHL have similar daily volatility (0.00).Check AVHHL's competition here
AMBBY vs JMDMF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, JMDMF has a market cap of 94.1M. Regarding current trading prices, AMBBY is priced at $10.32, while JMDMF trades at $3.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas JMDMF's P/E ratio is -13.68. In terms of profitability, AMBBY's ROE is +0.09%, compared to JMDMF's ROE of N/A. Regarding short-term risk, AMBBY and JMDMF have similar daily volatility (0.00).Check JMDMF's competition here
AMBBY vs RSHUF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, AMBBY is priced at $10.32, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, AMBBY's ROE is +0.09%, compared to RSHUF's ROE of -4.12%. Regarding short-term risk, AMBBY is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check RSHUF's competition here
AMBBY vs CKMTF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, AMBBY is priced at $10.32, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, AMBBY's ROE is +0.09%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, AMBBY and CKMTF have similar daily volatility (0.00).Check CKMTF's competition here
AMBBY vs SNZZF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, SNZZF has a market cap of 75M. Regarding current trading prices, AMBBY is priced at $10.32, while SNZZF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas SNZZF's P/E ratio is -4.77. In terms of profitability, AMBBY's ROE is +0.09%, compared to SNZZF's ROE of -0.41%. Regarding short-term risk, AMBBY and SNZZF have similar daily volatility (0.00).Check SNZZF's competition here
AMBBY vs BLOZF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, BLOZF has a market cap of 67.6M. Regarding current trading prices, AMBBY is priced at $10.32, while BLOZF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas BLOZF's P/E ratio is -13.96. In terms of profitability, AMBBY's ROE is +0.09%, compared to BLOZF's ROE of -2.60%. Regarding short-term risk, AMBBY is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check BLOZF's competition here
AMBBY vs TLTFF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, TLTFF has a market cap of 50.1M. Regarding current trading prices, AMBBY is priced at $10.32, while TLTFF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas TLTFF's P/E ratio is -19.50. In terms of profitability, AMBBY's ROE is +0.09%, compared to TLTFF's ROE of -3.15%. Regarding short-term risk, AMBBY is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check TLTFF's competition here
AMBBY vs BRNHF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, BRNHF has a market cap of 42.1M. Regarding current trading prices, AMBBY is priced at $10.32, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, AMBBY's ROE is +0.09%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, AMBBY and BRNHF have similar daily volatility (0.00).Check BRNHF's competition here
AMBBY vs RDGL Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, RDGL has a market cap of 40.9M. Regarding current trading prices, AMBBY is priced at $10.32, while RDGL trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas RDGL's P/E ratio is -8.99. In terms of profitability, AMBBY's ROE is +0.09%, compared to RDGL's ROE of -1.18%. Regarding short-term risk, AMBBY is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check RDGL's competition here
AMBBY vs PYNKF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, PYNKF has a market cap of 35.3M. Regarding current trading prices, AMBBY is priced at $10.32, while PYNKF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas PYNKF's P/E ratio is 5.61. In terms of profitability, AMBBY's ROE is +0.09%, compared to PYNKF's ROE of -2.30%. Regarding short-term risk, AMBBY is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check PYNKF's competition here
AMBBY vs NVYTF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, NVYTF has a market cap of 33.9M. Regarding current trading prices, AMBBY is priced at $10.32, while NVYTF trades at $0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas NVYTF's P/E ratio is -0.86. In terms of profitability, AMBBY's ROE is +0.09%, compared to NVYTF's ROE of -0.73%. Regarding short-term risk, AMBBY and NVYTF have similar daily volatility (0.00).Check NVYTF's competition here
AMBBY vs IPDQF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, IPDQF has a market cap of 28.5M. Regarding current trading prices, AMBBY is priced at $10.32, while IPDQF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas IPDQF's P/E ratio is -1.40. In terms of profitability, AMBBY's ROE is +0.09%, compared to IPDQF's ROE of -1.65%. Regarding short-term risk, AMBBY and IPDQF have similar daily volatility (0.00).Check IPDQF's competition here
AMBBY vs POSC Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, POSC has a market cap of 27.4M. Regarding current trading prices, AMBBY is priced at $10.32, while POSC trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas POSC's P/E ratio is 0.39. In terms of profitability, AMBBY's ROE is +0.09%, compared to POSC's ROE of -3.78%. Regarding short-term risk, AMBBY is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check POSC's competition here
AMBBY vs MKEAF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, MKEAF has a market cap of 25.9M. Regarding current trading prices, AMBBY is priced at $10.32, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, AMBBY's ROE is +0.09%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, AMBBY and MKEAF have similar daily volatility (0.00).Check MKEAF's competition here
AMBBY vs KBBTF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, AMBBY is priced at $10.32, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, AMBBY's ROE is +0.09%, compared to KBBTF's ROE of N/A. Regarding short-term risk, AMBBY and KBBTF have similar daily volatility (0.00).Check KBBTF's competition here
AMBBY vs EMITF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, EMITF has a market cap of 20.1M. Regarding current trading prices, AMBBY is priced at $10.32, while EMITF trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas EMITF's P/E ratio is -8.57. In terms of profitability, AMBBY's ROE is +0.09%, compared to EMITF's ROE of -0.14%. Regarding short-term risk, AMBBY and EMITF have similar daily volatility (0.00).Check EMITF's competition here
AMBBY vs DIZTF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, DIZTF has a market cap of 18M. Regarding current trading prices, AMBBY is priced at $10.32, while DIZTF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas DIZTF's P/E ratio is -11.16. In terms of profitability, AMBBY's ROE is +0.09%, compared to DIZTF's ROE of -0.72%. Regarding short-term risk, AMBBY is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check DIZTF's competition here
AMBBY vs GTHP Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, GTHP has a market cap of 16.7M. Regarding current trading prices, AMBBY is priced at $10.32, while GTHP trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas GTHP's P/E ratio is -4.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to GTHP's ROE of +0.70%. Regarding short-term risk, AMBBY is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check GTHP's competition here
AMBBY vs ASAPF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, ASAPF has a market cap of 15.9M. Regarding current trading prices, AMBBY is priced at $10.32, while ASAPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas ASAPF's P/E ratio is -20.34. In terms of profitability, AMBBY's ROE is +0.09%, compared to ASAPF's ROE of -0.32%. Regarding short-term risk, AMBBY is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check ASAPF's competition here
AMBBY vs MDXHF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, MDXHF has a market cap of 14.4M. Regarding current trading prices, AMBBY is priced at $10.32, while MDXHF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas MDXHF's P/E ratio is -4.40. In terms of profitability, AMBBY's ROE is +0.09%, compared to MDXHF's ROE of +0.58%. Regarding short-term risk, AMBBY and MDXHF have similar daily volatility (0.00).Check MDXHF's competition here
AMBBY vs VPTDF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, VPTDF has a market cap of 14.3M. Regarding current trading prices, AMBBY is priced at $10.32, while VPTDF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas VPTDF's P/E ratio is -4.14. In terms of profitability, AMBBY's ROE is +0.09%, compared to VPTDF's ROE of +1.07%. Regarding short-term risk, AMBBY is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check VPTDF's competition here
AMBBY vs TMDIF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, AMBBY is priced at $10.32, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, AMBBY's ROE is +0.09%, compared to TMDIF's ROE of +8.70%. Regarding short-term risk, AMBBY is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check TMDIF's competition here
AMBBY vs ATBPF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, AMBBY is priced at $10.32, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, AMBBY's ROE is +0.09%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, AMBBY is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check ATBPF's competition here
AMBBY vs LXXGF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, AMBBY is priced at $10.32, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, AMBBY's ROE is +0.09%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, AMBBY and LXXGF have similar daily volatility (0.00).Check LXXGF's competition here
AMBBY vs RMSL Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, RMSL has a market cap of 10.6M. Regarding current trading prices, AMBBY is priced at $10.32, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas RMSL's P/E ratio is 0.66. In terms of profitability, AMBBY's ROE is +0.09%, compared to RMSL's ROE of -12.31%. Regarding short-term risk, AMBBY is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check RMSL's competition here
AMBBY vs PMEDF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, PMEDF has a market cap of 8.5M. Regarding current trading prices, AMBBY is priced at $10.32, while PMEDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas PMEDF's P/E ratio is -2.05. In terms of profitability, AMBBY's ROE is +0.09%, compared to PMEDF's ROE of +1.24%. Regarding short-term risk, AMBBY and PMEDF have similar daily volatility (0.00).Check PMEDF's competition here
AMBBY vs PLLWF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, PLLWF has a market cap of 8M. Regarding current trading prices, AMBBY is priced at $10.32, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas PLLWF's P/E ratio is -0.66. In terms of profitability, AMBBY's ROE is +0.09%, compared to PLLWF's ROE of -0.99%. Regarding short-term risk, AMBBY and PLLWF have similar daily volatility (0.00).Check PLLWF's competition here
AMBBY vs ALRTF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, ALRTF has a market cap of 7.5M. Regarding current trading prices, AMBBY is priced at $10.32, while ALRTF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas ALRTF's P/E ratio is -0.30. In terms of profitability, AMBBY's ROE is +0.09%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, AMBBY and ALRTF have similar daily volatility (0.00).Check ALRTF's competition here
AMBBY vs USAQ Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, USAQ has a market cap of 6.4M. Regarding current trading prices, AMBBY is priced at $10.32, while USAQ trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas USAQ's P/E ratio is -14.25. In terms of profitability, AMBBY's ROE is +0.09%, compared to USAQ's ROE of +0.63%. Regarding short-term risk, AMBBY and USAQ have similar daily volatility (0.00).Check USAQ's competition here
AMBBY vs ODYY Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, ODYY has a market cap of 5.7M. Regarding current trading prices, AMBBY is priced at $10.32, while ODYY trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas ODYY's P/E ratio is -1.14. In terms of profitability, AMBBY's ROE is +0.09%, compared to ODYY's ROE of +0.58%. Regarding short-term risk, AMBBY is less volatile compared to ODYY. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check ODYY's competition here
AMBBY vs QLIS Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, AMBBY is priced at $10.32, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas QLIS's P/E ratio is 2.22. In terms of profitability, AMBBY's ROE is +0.09%, compared to QLIS's ROE of -0.60%. Regarding short-term risk, AMBBY and QLIS have similar daily volatility (0.00).Check QLIS's competition here
AMBBY vs RHNMF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, AMBBY is priced at $10.32, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, AMBBY's ROE is +0.09%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, AMBBY is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check RHNMF's competition here
AMBBY vs BIEL Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, BIEL has a market cap of 5.4M. Regarding current trading prices, AMBBY is priced at $10.32, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas BIEL's P/E ratio is N/A. In terms of profitability, AMBBY's ROE is +0.09%, compared to BIEL's ROE of +0.05%. Regarding short-term risk, AMBBY is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check BIEL's competition here
AMBBY vs ADMT Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, ADMT has a market cap of 5.4M. Regarding current trading prices, AMBBY is priced at $10.32, while ADMT trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas ADMT's P/E ratio is -8.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to ADMT's ROE of -0.01%. Regarding short-term risk, AMBBY and ADMT have similar daily volatility (0.00).Check ADMT's competition here
AMBBY vs NGMDF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, NGMDF has a market cap of 4.1M. Regarding current trading prices, AMBBY is priced at $10.32, while NGMDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas NGMDF's P/E ratio is -1.81. In terms of profitability, AMBBY's ROE is +0.09%, compared to NGMDF's ROE of +0.34%. Regarding short-term risk, AMBBY and NGMDF have similar daily volatility (0.00).Check NGMDF's competition here
AMBBY vs VANIW Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, AMBBY is priced at $10.32, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas VANIW's P/E ratio is N/A. In terms of profitability, AMBBY's ROE is +0.09%, compared to VANIW's ROE of -3.17%. Regarding short-term risk, AMBBY is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check VANIW's competition here
AMBBY vs CYDX Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, CYDX has a market cap of 3.3M. Regarding current trading prices, AMBBY is priced at $10.32, while CYDX trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas CYDX's P/E ratio is 0.82. In terms of profitability, AMBBY's ROE is +0.09%, compared to CYDX's ROE of +0.13%. Regarding short-term risk, AMBBY and CYDX have similar daily volatility (0.00).Check CYDX's competition here
AMBBY vs VYCO Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, VYCO has a market cap of 3M. Regarding current trading prices, AMBBY is priced at $10.32, while VYCO trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas VYCO's P/E ratio is -9.00. In terms of profitability, AMBBY's ROE is +0.09%, compared to VYCO's ROE of +0.00%. Regarding short-term risk, AMBBY and VYCO have similar daily volatility (0.00).Check VYCO's competition here
AMBBY vs FZMD Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, FZMD has a market cap of 2.6M. Regarding current trading prices, AMBBY is priced at $10.32, while FZMD trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas FZMD's P/E ratio is 1.17. In terms of profitability, AMBBY's ROE is +0.09%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, AMBBY and FZMD have similar daily volatility (0.00).Check FZMD's competition here
AMBBY vs TBRIF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, TBRIF has a market cap of 2.2M. Regarding current trading prices, AMBBY is priced at $10.32, while TBRIF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas TBRIF's P/E ratio is -0.76. In terms of profitability, AMBBY's ROE is +0.09%, compared to TBRIF's ROE of +16.81%. Regarding short-term risk, AMBBY and TBRIF have similar daily volatility (0.00).Check TBRIF's competition here
AMBBY vs LLBO Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, LLBO has a market cap of 1.7M. Regarding current trading prices, AMBBY is priced at $10.32, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas LLBO's P/E ratio is N/A. In terms of profitability, AMBBY's ROE is +0.09%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, AMBBY and LLBO have similar daily volatility (0.00).Check LLBO's competition here
AMBBY vs KLYG Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, KLYG has a market cap of 1.5M. Regarding current trading prices, AMBBY is priced at $10.32, while KLYG trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas KLYG's P/E ratio is -12.01. In terms of profitability, AMBBY's ROE is +0.09%, compared to KLYG's ROE of -1.24%. Regarding short-term risk, AMBBY and KLYG have similar daily volatility (0.00).Check KLYG's competition here
AMBBY vs VRSEF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, VRSEF has a market cap of 1.4M. Regarding current trading prices, AMBBY is priced at $10.32, while VRSEF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas VRSEF's P/E ratio is 0.14. In terms of profitability, AMBBY's ROE is +0.09%, compared to VRSEF's ROE of +1.00%. Regarding short-term risk, AMBBY and VRSEF have similar daily volatility (0.00).Check VRSEF's competition here
AMBBY vs ESMC Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, ESMC has a market cap of 1.2M. Regarding current trading prices, AMBBY is priced at $10.32, while ESMC trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas ESMC's P/E ratio is -5.37. In terms of profitability, AMBBY's ROE is +0.09%, compared to ESMC's ROE of -125.28%. Regarding short-term risk, AMBBY is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for AMBBY.Check ESMC's competition here
AMBBY vs UAHC Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, UAHC has a market cap of 1.1M. Regarding current trading prices, AMBBY is priced at $10.32, while UAHC trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas UAHC's P/E ratio is 0.53. In terms of profitability, AMBBY's ROE is +0.09%, compared to UAHC's ROE of +0.04%. Regarding short-term risk, AMBBY and UAHC have similar daily volatility (0.00).Check UAHC's competition here
AMBBY vs NUMD Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, NUMD has a market cap of 919K. Regarding current trading prices, AMBBY is priced at $10.32, while NUMD trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas NUMD's P/E ratio is 1.10. In terms of profitability, AMBBY's ROE is +0.09%, compared to NUMD's ROE of +0.23%. Regarding short-term risk, AMBBY and NUMD have similar daily volatility (0.00).Check NUMD's competition here
AMBBY vs ELXMF Comparison March 2026
AMBBY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMBBY stands at 2.7B. In comparison, ELXMF has a market cap of 541.2K. Regarding current trading prices, AMBBY is priced at $10.32, while ELXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMBBY currently has a P/E ratio of 32.24, whereas ELXMF's P/E ratio is -0.09. In terms of profitability, AMBBY's ROE is +0.09%, compared to ELXMF's ROE of -0.40%. Regarding short-term risk, AMBBY and ELXMF have similar daily volatility (0.00).Check ELXMF's competition here